U.S. flag

An official website of the United States government

NM_000258.3(MYL3):c.235G>A (p.Val79Ile) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 26, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002453474.2

Allele description [Variation Report for NM_000258.3(MYL3):c.235G>A (p.Val79Ile)]

NM_000258.3(MYL3):c.235G>A (p.Val79Ile)

Gene:
MYL3:myosin light chain 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p21.31
Genomic location:
Preferred name:
NM_000258.3(MYL3):c.235G>A (p.Val79Ile)
HGVS:
  • NC_000003.12:g.46860748C>T
  • NG_007555.2:g.26422G>A
  • NM_000258.3:c.235G>AMANE SELECT
  • NP_000249.1:p.Val79Ile
  • NP_000249.1:p.Val79Ile
  • LRG_395t1:c.235G>A
  • LRG_395:g.26422G>A
  • LRG_395p1:p.Val79Ile
  • NC_000003.11:g.46902238C>T
  • NM_000258.2:c.235G>A
Protein change:
V79I
Links:
dbSNP: rs150634297
NCBI 1000 Genomes Browser:
rs150634297
Molecular consequence:
  • NM_000258.3:c.235G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002735742Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Sep 26, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A novel Myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivity.

Andersen PS, Hedley PL, Page SP, Syrris P, Moolman-Smook JC, McKenna WJ, Elliott PM, Christiansen M.

Biochem Res Int. 2012;2012:685108. doi: 10.1155/2012/685108. Epub 2012 Apr 11.

PubMed [citation]
PMID:
22957257
PMCID:
PMC3432877

Cardiomyopathies: classification, clinical characterization, and functional phenotypes.

Szczesna-Cordary D, Morimoto S, Gomes AV, Moore JR.

Biochem Res Int. 2012;2012:870942. doi: 10.1155/2012/870942. Epub 2012 Dec 4. No abstract available.

PubMed [citation]
PMID:
23304510
PMCID:
PMC3529434
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV002735742.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The p.V79I variant (also known as c.235G>A), located in coding exon 3 of the MYL3 gene, results from a G to A substitution at nucleotide position 235. The valine at codon 79 is replaced by isoleucine, an amino acid with highly similar properties. This variant was detected in an asymptomatic individual with hypertrophic cardiomyopathy (HCM), as well as in three family members with borderline HCM findings and in six unaffected carrier family members, including some who were children at the time of evaluation (Andersen PS et al. Biochem Res Int, 2012 Apr;2012:685108). This variant has also been reported as a secondary finding in exome cohorts with limited clinical details provided (Lawrence L et al. Genet Med, 2014 Oct;16:741-50; Olfson E et al. PLoS One, 2015 Sep;10:e0135193). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024